Related references
Note: Only part of the references are listed.Invasion and metastasis: the elusive hallmark of cancer
Tomer Meirson et al.
ONCOGENE (2020)
Metastasis-free survival as a predictor of overall survival in non-metastatic castration-resistant prostate cancer.
Richard Gagnon et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Solid cancer: the new tumour spread endpoint opens novel opportunities
Michael Fernandes et al.
BRITISH JOURNAL OF CANCER (2019)
Metastasis-free Survival - A New End Point in Prostate Cancer Trials
Julia A. Beaver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2Hi Macrophages in Breast Cancer and Pancreatic Neuroendocrine Tumors
Allison S. Harney et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism
George S. Karagiannis et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Migrastatics-Anti-metastatic and Anti-invasion Drugs: Promises and Challenges
Aneta Gandalovicova et al.
TRENDS IN CANCER (2017)
MenaINV dysregulates cortactin phosphorylation to promote invadopodium maturation
Maxwell D. Weidmann et al.
SCIENTIFIC REPORTS (2016)
Menacalc, a quantitative method of metastasis assessment, as a prognostic marker for axillary node-negative breast cancer
Catherine L. Forse et al.
BMC CANCER (2015)
Invasive breast carcinoma cells from patients exhibit MenaINV- and macrophage-dependent transendothelial migration
Jeanine Pignatelli et al.
SCIENCE SIGNALING (2014)
Quantitative assessment of invasive mena isoforms (Menacalc) as an independent prognostic marker in breast cancer
Seema Agarwal et al.
BREAST CANCER RESEARCH (2012)
Share Paper
